- Home Page
- Company Profile
-
Our Products
- Anti Cancer Capsule
-
Anti Cancer Injection
- 300 mcg Filgrastim Injection
- Nimotuzumab Injection
- 2 Mg Bortezomib Injection
- 440 mg Trastuzumab Injection
- 40 mcg Darbepoetin Alfa Injection
- 1000 mg Gemcitabine Injection
- 38 mg Gemcitabine Injection
- 300 mcg Filgrastim Injection
- 260 mg Paclitaxel Injection
- 450 mg Carboplatin Injection
- 3.75 mg Leuprolide Acetate Injection
- 6 mg Pegfilgrastim Injection
- Pegfilgrastim Injection
- Anti Cancer Tablet
- Anti Cancer Medicine
- Nefroglogy Medicine
- HIV Medicine
- Contact Us
X
Anastrozole Tablet
Product Details:
- Drug Type General Medicines
- Physical Form Tablets
- Function Anti-Cancer
- Dosage As per doctor Recommendation
- Suitable For Suitable For All
- Storage Instructions Dry place
- Click to view more
X
Price And Quantity
- 50 Box
Product Specifications
- Dry place
- Tablets
- Anti-Cancer
- Suitable For All
- As per doctor Recommendation
- General Medicines
Trade Information
- Cash in Advance (CID)
- AS per Requirement Per Month
- As per Location Days
- Yes
- Contact us for information regarding our sample policy
- All India
Product Description
Anastrozole Tablet that brought by us is ideal medication in the treatment of breast cancer after surgery. This type of medicine works by decreasing the amount of the hormone, which is called estrogen. The Anastrozole that contains in this tablet is an active ingredient. This is prescribed by expert doctors all over the globe for its high effectiveness, balanced composition of required substances, negligible side-effects, and good shelf life. The Anastrozole Tablet is easy swallow, and comes into calendar pack of 2x14 tablets.
Other Products in 'Anti Cancer Tablet' category
Contact Details
GALAXY LIFE CARE
Plot No 8, Office No 301, 3rd Floor, Chopra Commercial Complex, Delhi - 110092, India
Mr Gopal Jha
(Proprietor)
|
|
|
 |
|
Getdistributors.comSME TimesBlog
India's Largest B2B Marketplace, Connecting Buyers and Sellers.
Privacy Policy- Terms of Use © 1999-2017 Infocom Network Limited. All rights reserved.